Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » North America

North America

Mar 26, 2021

Dascena Labs, Ginkgo Bioworks Partner to Scale Pooled SARS-CoV-2 Testing in Schools

The labs will provide testing for K-12 schools by testing each consenting person in a classroom as one pool.

Mar 26, 2021

Co-Diagnostics 2020 Revenues Spike on Coronavirus Testing

Before launching its COVID-19 test, which generated most of Co-Diagnostics' revenues in 2020, the firm's sales primarily came from mosquito-borne virus testing.

Mar 25, 2021

HTG Molecular Diagnostics FY 2020 Revenues Fall 56 Percent

For the year ended Dec. 31, 2020, the firm reported revenues of $8.5 million compared to $19.2 million in 2019, beating the Wall Street estimate of $8.3 million. 

Mar 25, 2021

Aspira Q4 Revenues Up 11 Percent, Firm Inks Deal for Ovarian Cancer Detection Tech

The agreement is with the Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Medical University Lodz.

Mar 25, 2021

OpGen Fourth Quarter Revenues Increase 64 Percent

The company's full-year revenues were $4.2 million, up 20 percent from the year-ago quarter.

Mar 25, 2021

SARS-CoV-2 Study Implicates Saliva in Viral Transmission

Viral entry factors were broadly enriched in the salivary glands and oral mucosae, implicating the oral cavity as an important infection site.

Mar 25, 2021

Immunai Using Acquisition, Funding to Shift Into Functional Work

Premium

The immune profiling company is looking to expand its functional genomics capabilities to more directly inform immune therapy development and application.

Mar 25, 2021

Wild Animal Gut Microbiomes Reveal New Species, Ties to Host Traits

The gut microbiomes of nearly 200 animal species could serve as a resource for the discovery of new therapeutics and biotechnology applications.

Mar 25, 2021

Moncef Slaoui Fired

The Wall Street Journal reports Moncef Slaoui has been fired from a biotech startup following allegations of sexual harassment.

Mar 25, 2021

New Numbers

In a new analysis, AstraZeneca says its SARS-CoV-2 vaccine is 76 percent effective in preventing symptomatic COVID-19, the Associated Press reports.

Pages

The Scan

Pause Recommended

The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.

Science and a Side of Diplomacy

According to the Associated Press, a Swiss program aims to shepherd long-term science projects and diplomacy.

New Studies of B.1.1.7

CNN reports that two new studies suggest the B.1.1.7 SARS-CoV-2 variant may be more transmissible, but may not lead to more severe disease.

PNAS Papers on Acute Kidney Injury, Parental Expression in Horse Placenta, Sea Urchin Microbes

In PNAS this week: analysis of pathway affecting acute kidney injury, parental-specific allelic expression in horse placenta, and more.

What's Popular?

In North America

  1. DiaSorin to Acquire Luminex for $1.8B

  2. CRISPR-Cas9 Genome Editing Can Lead to Extensive Chromosome Rearrangements

  3. Amazon to Give Out $12M Under Next Phase of AWS Diagnostics Development Initiative

  4. NCI Director Sharpless Outlines Ideas to Aggressively Lower Cancer Deaths

  5. Thermo Fisher Scientific Gets FDA EUA for High-Throughput, Automated COVID-19 Test Kit

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.